Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection

BACKGROUND: Haemodialysis patients are at risk of developing severe forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: coronavirus disease 2019 (COVID-19). In March 2020, hydroxychloroquine (HCQ) and azithromycin (AZI) were proposed as potential treatments of COVID-19,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nephrol Dial Transplant
Main Authors: Giaime, Philippe, Guenoun, Maxime, Pedinielli, Nathalie, Narbonne, Hervé, Bergounioux, Jean-Philippe, Solas, Caroline, Guilhaumou, Romain, Sampol, Jérôme, Ollier, Jacques, Sichez, Hélène, Serveaux, Marianne, Brunner, Flora, Bataille, Stanislas
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499716/
https://ncbi.nlm.nih.gov/pubmed/32844224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfaa191
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados